GCP
ABBV icon

Guardian Capital (Pennsylvania)’s AbbVie ABBV Stock Holding History

Guardian Capital (Pennsylvania)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$240K Buy
955
+5
+0.5% +$1.08K 0.2% 72
2026
Q1 		$207K Sell
950
-606
-39% -$134K 0.2% 81
2025
Q4 		$355K Buy
+1,556
New +$354K 0.32% 71

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Guardian Capital (Pennsylvania)'s ABBV Position: Q2 2026 in Review

Guardian Capital (Pennsylvania) increased its AbbVie (ABBV) stake by 0.53% in Q2 2026, buying an estimated $1.08K and bringing the position to 955 shares worth $240K. The position accounts for 0.2% of the portfolio, ranked #72.

Guardian Capital (Pennsylvania) first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $355K in Q4 2025. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guardian Capital (Pennsylvania) held 955 shares of AbbVie worth $240K as of Q2 2026.
  • Guardian Capital (Pennsylvania) bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.2% of Guardian Capital (Pennsylvania)'s portfolio in Q2 2026, its #72 holding.
  • Guardian Capital (Pennsylvania) first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Guardian Capital (Pennsylvania)'s AbbVie position peaked at $355K in Q4 2025.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guardian Capital (Pennsylvania)'s 13F filing for Q2 2026, filed 7 Aug 2026.